首页> 外文期刊>Biomedical Chromatography: An International Journal Devoted to Research in Chromatographic Methodologies and Their Applications in the Biosciences >Limitation of immunoaffinity column for the removal of abundant proteins from plasma in quantitative plasma proteomics.
【24h】

Limitation of immunoaffinity column for the removal of abundant proteins from plasma in quantitative plasma proteomics.

机译:定量亲和蛋白质组学中从血浆中去除大量蛋白质的免疫亲和柱的局限性。

获取原文
获取原文并翻译 | 示例
       

摘要

In plasma proteomics, before a proteome analysis, it is essential to prepare protein samples without high-abundance proteins, including albumin, via specific preparation techniques, such as immunoaffinity capture. However, our preliminary experiments suggested that functional changes with use alter the ability of the immunoaffinity column. Thus, in this study, to evaluate the changes of the removal ability of abundant proteins from plasma by the immunoaffinity column, plasma proteome analysis was performed for the long-term test for the reproducibility of the affinity column using the fluorogenic derivatization-liquid chromatography-tandem mass spectrometry method combined with an IgY column. The specific adsorption for albumin decreased with an increase in the number of the column usage before its expiration date. Moreover, it was demonstrated that hydrophobic high molecular weight compounds in plasma adsorbed onto the column materials surface contributed to the functional changes from specific immunoaffinity adsorption into hydrophobic interaction. These results suggested that, in quantitative plasma proteomics studies, it is important to keep in mind the risk of not only the nonselective loss but also the changes in the adsorption ability of the immunoafinity column.
机译:在血浆蛋白质组学中,在进行蛋白质组分析之前,必须通过特定的制备技术(例如免疫亲和捕获)制备不含高蛋白(包括白蛋白)的蛋白质样品。但是,我们的初步实验表明,随着使用功能的改变会改变免疫亲和柱的能力。因此,在这项研究中,为了评估免疫亲和柱从血浆中去除大量蛋白质的能力的变化,使用荧光衍生化-液相色谱法对血浆蛋白组分析进行了亲和柱重现性的长期测试,串联质谱法结合IgY色谱柱白蛋白的特异性吸附随着有效期之前色谱柱使用次数的增加而降低。此外,已证明血浆中的疏水性高分子量化合物吸附在柱材料表面上,有助于功能从特定的免疫亲和吸附转变为疏水性相互作用。这些结果表明,在定量血浆蛋白质组学研究中,重要的是要牢记不仅发生非选择性损失的风险,而且还要考虑免疫亲和柱吸附能力变化的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号